THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Johnson & Johnson and Sail Biomedicines announced strategic agreements to advance Sail’s in vivo CAR-T platform for immune-mediated diseases, with an option for Johnson & Johnson to acquire Sail.
- Current status
- Official collaboration
- Known availability
- The official source confirms the collaboration; timing details remain under review.
- Place
- New Brunswick, United States
- Source checked
- September 16, 2026
FOLLOW THE STORY